IP Library Assignment 022673/0701
Patent Assignment
Reel/Frame 022673/0701

Assignment of Assignor's Interest

Recorded: 2009-05-12 Pages: 4
Assignors
BRITTAIN, PHD, HARRY G.
Executed: 2009-03-03
FELICE, M.D., PHILIP V.
Executed: 2009-02-28
Assignee
SOLUPRIN PHARMACEUTICALS, INC.
100 PARK AVENUE, SUITE 1600, NEW YORK, NEW YORK, 10017
Covered Property (1)
Intravenous Formulation with Water-Soluble Cocrystals of Acetylsalicylic Acid and Theanine
Patent: 8,173,625 →
Application: 12/437,735 →
Publication: US 2010/0286099
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Feb 6, 2012
From: SOLUPRIN PHARMACEUTICALS, INC.
To: THEAPRIN PHARMACEUTICALS INC.
Reel/Frame 027655/0352 →
Corrective Assignment to Correct the Address of the Assignee Previously Recorded on Reel 027655 Frame 0352. Assignor(S) Hereby Confirms the Assignment. Feb 8, 2012
From: SOLUPRIN PHARMACEUTICALS, INC.
To: THERAPRIN PHARMACEUTICALS INC.
Reel/Frame 027675/0408 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 027675 Frame 0408. Assignor(S) Hereby Confirms the Corrective Assignment of a Change of Name. Apr 6, 2012
From: SOLUPRIN PHARMACEUTICALS, INC.
To: THEAPRIN PHARMACEUTICALS INC.
Reel/Frame 028003/0601 →